Call for more patient-centered drug development in oncology — NEJM

In an article in the New England Journal of Medicine (NEJM), published online on 3 July 2013, Dr Ethan Basch highlights the lack of information on how a drug will make patients feel in the US label of most new cancer drugs.  … Continue reading

The value of developing a good TPP for your product in early development

There have recently been a number of articles in biopharma publications and social media suggesting that the target product profile (or TPP) is an enemy of innovation and and reduces productivity in the industry.  The authors of these articles suggest … Continue reading